What is the recommended treatment for a patient with meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Meningitis

The recommended empirical treatment for bacterial meningitis in adults is ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours, with the addition of amoxicillin 2g IV every 4 hours in patients ≥60 years old. 1

Empirical Antibiotic Therapy

  • For adults under 60 years old, empirical treatment should consist of:

    • Ceftriaxone 2g IV every 12 hours OR
    • Cefotaxime 2g IV every 6 hours 1
    • Alternative: Chloramphenicol 25 mg/kg IV every 6 hours (for patients with severe beta-lactam allergies) 1, 2
  • For adults 60 years and older, empirical treatment should include:

    • Ceftriaxone 2g IV every 12 hours OR
    • Cefotaxime 2g IV every 6 hours
    • PLUS
    • Amoxicillin 2g IV every 4 hours (to cover Listeria monocytogenes) 1
    • Alternative: Chloramphenicol 25 mg/kg IV every 6 hours AND co-trimoxazole 10-20 mg/kg (of trimethoprim component) in four divided doses 1
  • Add vancomycin 15-20 mg/kg IV every 12 hours OR rifampicin 600 mg twice daily if penicillin-resistant pneumococci are suspected (e.g., patient recently arrived from a country with high prevalence of resistance) 1

Pathogen-Specific Treatment

Streptococcus pneumoniae

  • For penicillin-sensitive pneumococci (MIC ≤0.06 mg/L):

    • Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours OR
    • Switch to benzylpenicillin 2.4g IV every 4 hours 1
    • Duration: 10 days if stable; up to 14 days if slower response 1
  • For penicillin-resistant but cephalosporin-sensitive pneumococci:

    • Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 1
    • Duration: 10 days if stable; up to 14 days if slower response 1
  • For penicillin and cephalosporin-resistant pneumococci:

    • Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours
    • PLUS vancomycin 15-20 mg/kg IV every 12 hours
    • PLUS rifampicin 600 mg IV/orally twice daily 1
    • Duration: 14 days 1

Neisseria meningitidis

  • Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours OR
  • Switch to benzylpenicillin 2.4g IV every 4 hours 1, 2
  • If not treated with ceftriaxone, add a single dose of ciprofloxacin 500 mg orally 1
  • Duration: 5 days if clinical recovery is observed 1, 2

Listeria monocytogenes

  • Amoxicillin 2g IV every 4 hours
  • Alternative: Co-trimoxazole 10-20 mg/kg (of trimethoprim component) in four divided doses 1
  • Duration: 21 days 1

Haemophilus influenzae

  • Cefotaxime 2g IV every 6 hours
  • Alternative: Moxifloxacin 400 mg once daily 1
  • Duration: 10 days 1

Special Considerations

  • For pediatric patients with bacterial meningitis, meropenem is FDA-approved for treatment of meningitis caused by H. influenzae, N. meningitidis, and penicillin-susceptible S. pneumoniae at a dose of 40 mg/kg (maximum 2g) every 8 hours 3

  • In children, combination treatment with cefotaxime (300 mg/kg per day) or ceftriaxone (100 mg/kg per day) and vancomycin (60 mg/kg per day) is recommended as first-line therapy when pneumococcal meningitis cannot be ruled out 4

  • Ceftriaxone should be administered intravenously over 30 minutes in adults, but over 60 minutes in neonates to reduce the risk of bilirubin encephalopathy 5

Monitoring and Follow-up

  • If the patient is not improving clinically, consider:
    • Obtaining susceptibility testing and adjusting antibiotics accordingly 2
    • Extending treatment duration 2
    • Repeating lumbar puncture, especially in pneumococcal meningitis with uncertain susceptibility 1

Common Pitfalls to Avoid

  • Do not delay treatment while waiting for culture results if bacterial meningitis is suspected 2
  • Do not use rifampin as monotherapy due to the risk of developing resistance 2
  • Do not discontinue therapy prematurely, even if clinical improvement occurs rapidly, as this may lead to relapse 2
  • Do not use diluents containing calcium (e.g., Ringer's solution) to reconstitute ceftriaxone due to risk of precipitation 5
  • Do not administer ceftriaxone simultaneously with calcium-containing IV solutions 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Neisseria Meningitidis in Sputum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.